Article info

Efficacy and safety of vasopressin and terlipressin in preterm neonates: a protocol for a systematic review

Authors

  • Abdulrahman Salim Alsaadi Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  • Katelyn Sushko Faculty of Health Sciences, School of Nursing, McMaster University, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  • Vivian Bui Department of Pharmacy, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  • John Van Den Anker Department of Pediatrics and Pharmacology and Pharmacometric, University Children’s Hospital Basel, Basel, SwitzerlandDivision of Clinical Pharmacology, Children’s National Hospital, Washintgon, DC, USAIntensive Care and Department of Pediatric Surgery, Erasmus MC Sophia Children’s Hospital, Rotterdam, Netherlands PubMed articlesGoogle scholar articles
  • Abdul Razak Department of Pediatrics, Princess Norah Bint Abdulrahman University, Riyadh, Saudi ArabiaDivision of Neonatology, Department of Pediatrics, King Abdullah bin Abdulaziz University Hospital, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia PubMed articlesGoogle scholar articles
  • Samira Samiee-Zafarghandy Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Abdulrahman Salim Alsaadi; dr-abdul-alsaadi{at}hotmail.com
View Full Text

Citation

Alsaadi AS, Sushko K, Bui V, et al
Efficacy and safety of vasopressin and terlipressin in preterm neonates: a protocol for a systematic review

Publication history

  • Received February 16, 2021
  • Accepted May 13, 2021
  • First published June 9, 2021.
Online issue publication 
June 09, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.